TODD Pharm Selected for Novo Nordisk Partnering Day – Korea 2024

TODD Pharm was selected for a 1:1 partnering meeting at the Novo Nordisk Partnering Day, as our innovative FGF21 patent was recognized as a technology of interest by Novo Nordisk